Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toru Hiraga

Showing results (1-10 of 83) with videos related to

Pageof 9
Sort By:
Expert Opinion on Investigational Drugs|January 19, 2016
Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone MetastasesToru Hiraga
Clinical Calcium|July 29, 2014
[Molecular mechanisms of bone cancer pain]Toru Hiraga
Journal of Oral Biosciences|May 22, 2019
Bone metastasis: Interaction between cancer cells and bone microenvironmentToru Hiraga
Bone|November 16, 2024
Immune microenvironment of cancer bone metastasisToru Hiraga
Calcified Tissue International|July 2, 2026
Cytokine Networks Reprogramming the Osteo-Immune Microenvironment in Cancer Bone MetastasisToru Hiraga
Clinical Calcium|January 7, 2006
[Molecular targets for the treatment of bone metastases]Toru Hiraga
International Journal of Molecular Sciences|November 15, 2018
Hypoxic Microenvironment and Metastatic Bone DiseaseToru Hiraga
International Journal of Oncology|February 16, 2024
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)Toru Hiraga
Oncology Letters|October 5, 2016
Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse modelToru Hiraga, Hiroaki Nakamura
Journal of Bone and Mineral Metabolism|April 19, 2018
Establishment and characterization of a C57BL/6 mouse model of bone metastasis of breast cancerToru Hiraga, Tadashi Ninomiya
Pageof 9

Showing results (1-10 of 83) with videos related to

Sort By:
Pageof 9
Expert Opinion on Investigational Drugs|January 19, 2016
Targeted Agents in Preclinical and Early Clinical Development for the Treatment of Cancer Bone MetastasesToru Hiraga
Clinical Calcium|July 29, 2014
[Molecular mechanisms of bone cancer pain]Toru Hiraga
Journal of Oral Biosciences|May 22, 2019
Bone metastasis: Interaction between cancer cells and bone microenvironmentToru Hiraga
Bone|November 16, 2024
Immune microenvironment of cancer bone metastasisToru Hiraga
Calcified Tissue International|July 2, 2026
Cytokine Networks Reprogramming the Osteo-Immune Microenvironment in Cancer Bone MetastasisToru Hiraga
Clinical Calcium|January 7, 2006
[Molecular targets for the treatment of bone metastases]Toru Hiraga
International Journal of Molecular Sciences|November 15, 2018
Hypoxic Microenvironment and Metastatic Bone DiseaseToru Hiraga
International Journal of Oncology|February 16, 2024
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review)Toru Hiraga
Oncology Letters|October 5, 2016
Comparable roles of CD44v8-10 and CD44s in the development of bone metastases in a mouse modelToru Hiraga, Hiroaki Nakamura
Journal of Bone and Mineral Metabolism|April 19, 2018
Establishment and characterization of a C57BL/6 mouse model of bone metastasis of breast cancerToru Hiraga, Tadashi Ninomiya
Pageof 9